Skip to main content
. 2022 May 29;2022:3485757. doi: 10.1155/2022/3485757

Table 7.

SGRQ before and after herbal medicine treatments.

Total (n = 24) Asthma (n = 14) COPD (n = 10)
Symptom
 Baseline 62.91 (55.81, 70.00) 70.73 (63.52, 77.93) 51.95 (40.25, 63.66)
 Week 12 56.26 (47.36, 65.17) 63.38 (51.24, 75.53) 46.30 (35.50, 57.09)
p value 0.0732 0.1527 0.3084
Activity
 Baseline 47.41 (38.54, 56.28) 44.14 (34.40, 53.89) 51.99 (33.37, 70.60)
 Week 12 45.35 (33.78, 56.92) 47.06 (30.98, 63.15) 42.95 (26.46, 59.44)
p value 0.6796 0.6514 0.2153
Impact
 Baseline 30.66 (23.20, 38.13) 34.94 (25.12, 44.77) 24.67 (12.04, 37.30)
 Week 12 27.00 (19.02, 34.98) 34.50 (23.71, 45.28) 16.51 (6.88, 26.14)
p value 0.1066 0.8903 0.0147
Total
 Baseline 46.99 (40.77, 53.22) 49.94 (41.97, 57.91) 42.87 (31.62, 54.12)
 Week 12 42.87 (34.76, 50.98) 48.32 (37.01, 59.62) 35.25 (25.23, 45.26)
p value 0.1190 0.6574 0.0265

Data are presented as mean (95% CI). p value by paired t-test (p < 0.05).